RSS   Newsletter   Contact   Advertise with us
Post Online Media
Post Online Media Magazine

Immunome appoints Purnanand Sarma as president and CEO

Share on Twitter Share on LinkedIn
Christian Fernsby | Exton, Pa., USA | June 25, 2019
Purnanand SarmaImmunome, a biotechnology company, announced that Purnanand Sarma has joined as president and chief executive officer.
Mr. Sarma brings more than 25 years of industry experience with a proven track record in drug development, fund raising, and growing companies.

Prior to joining Immunome, Mr. Sarma was the President and CEO of Taris Biomedical.

Prior to TARIS, he served in several leadership roles at Cephalon Corporation, which was acquired by Teva Pharmaceutical Industries; Nektar Therapeutics; and SmithKline Beecham, now Glaxo SmithKline.

Mr. Sarma earned his PhD in Pharmaceutics from the University of Minnesota and B. Pharm from Andhra University, Visakhapatnam, India.

Mr. Sarma serves as an independent Board Member at Ohm Oncology and Vaxess Technologies Inc.


 LATEST MOVES FROM Pennsylvania 


POST Online Media Contact